Literature DB >> 1519662

In situ hybridization and immunohistochemistry of p53 tumor suppressor gene in human esophageal carcinoma.

H Sasano1, Y Goukon, T Nishihira, H Nagura.   

Abstract

We have studied expression of p53, a tumor suppressor gene, by using both immunohistochemistry and in situ hybridization in 20 cases of squamous cell carcinoma of the esophagus. Immunohistochemical analysis was performed by using monoclonal antibody pAb1801. Immunoreactive p53 was observed in the nuclei of the tumor cells in 17 cases. We used 35S-labeled anti-sense single-stranded synthetic oligonucleotide probe ON102, which hybridized with DNA sequence near the 5' end of p53, for in situ hybridization. In all the cases of invasive squamous cell carcinoma studied, no significant accumulation of p53 hybridization signals was observed in carcinoma cells. This result indicates that overexpression of p53 observed by immunohistochemical staining is not due to an increase in the steady-state level of p53 mRNA in frank carcinoma cells. In six cases of morphologically normal esophageal mucosa distant from carcinoma, accumulation of hybridization signals was observed in basal and parabasal cells of the mucosa. The mucosa of these cases was negative for p53 immunoreactivity except for one case showing sporadic positivity. Accumulation of hybridization signals was observed in foci of squamous dysplasia not associated with invasion in three cases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1519662      PMCID: PMC1886688     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Overexpression and mutation of p53 in epithelial ovarian cancer.

Authors:  J R Marks; A M Davidoff; B J Kerns; P A Humphrey; J C Pence; R K Dodge; D L Clarke-Pearson; J D Iglehart; R C Bast; A Berchuck
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

2.  Frequent mutation of the p53 gene in human esophageal cancer.

Authors:  M C Hollstein; R A Metcalf; J A Welsh; R Montesano; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction.

Authors:  S J Meltzer; J Yin; Y Huang; T K McDaniel; C Newkirk; O Iseri; B Vogelstein; J H Resau
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Genetic basis for p53 overexpression in human breast cancer.

Authors:  A M Davidoff; P A Humphrey; J D Iglehart; J R Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

5.  17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma.

Authors:  P L Blount; S Ramel; W H Raskind; R C Haggitt; C A Sanchez; P J Dean; P S Rabinovitch; B J Reid
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

6.  Co-localization of EGF transcripts and peptides by combined immunohistochemistry and in situ hybridization.

Authors:  R I Couwenhoven; W Luo; M L Snead
Journal:  J Histochem Cytochem       Date:  1990-12       Impact factor: 2.479

7.  Modulation of p53 gene expression and cytokeratin 18 in retinoid-mediated invasion suppressed lung carcinoma cells.

Authors:  N Ledinko; R L Costantino
Journal:  Anticancer Res       Date:  1990 Sep-Oct       Impact factor: 2.480

8.  Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens.

Authors:  A Puisieux; S Lim; J Groopman; M Ozturk
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

9.  p53 gene mutations in Barrett's epithelium and esophageal cancer.

Authors:  A G Casson; T Mukhopadhyay; K R Cleary; J Y Ro; B Levin; J A Roth
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

10.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

View more
  7 in total

1.  Translational regulation of human p53 gene expression.

Authors:  L Fu; M D Minden; S Benchimol
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

2.  Expression of p53 protein related to human papillomavirus and DNA ploidy in superficial esophageal carcinoma.

Authors:  T Nakamura; H Ide; R Eguchi; K Hayashi; F Hanyu; K Nagasako; M Yukawa; K Asaka; T Fujimori; S Maeda
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

3.  Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21.

Authors:  Y Hayashi; N Ishii; C Obayashi; K Jinnai; K Hanioka; Y Imai; H Itoh
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Immunohistochemical analysis of p53 expression in anal squamous neoplasia.

Authors:  O A Ogunbiyi; J H Scholefield; J H Smith; S V Polacarz; K Rogers; F Sharp
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

5.  Esophageal squamous cell carcinoma: pathology and prognosis.

Authors:  H Ide; T Nakamura; K Hayashi; T Endo; A Kobayashi; R Eguchi; F Hanyu
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

6.  Tissue array for Tp53, C-myc, CCND1 gene over-expression in different tumors.

Authors:  Guo-Yan Liu; Qi Luo; Bin Xiong; Chao Pan; Ping Yin; Hong-Feng Liao; Wei-Chun Zhuang; Hong-Zhi Gao
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

7.  Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.

Authors:  Joshua Z Press; Alessandro De Luca; Niki Boyd; Sean Young; Armelle Troussard; Yolanda Ridge; Pardeep Kaurah; Steve E Kalloger; Katherine A Blood; Margaret Smith; Paul T Spellman; Yuker Wang; Dianne M Miller; Doug Horsman; Malek Faham; C Blake Gilks; Joe Gray; David G Huntsman
Journal:  BMC Cancer       Date:  2008-01-22       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.